logo
Plus   Neg
Share
Email

Moderna Issues Statement On Adverse Events At Vaccination Center

Moderna (MRNA) said the company is fully cooperating with the California Department of Public Health (CDPH) in investigating the adverse events at one vaccination center from one lot of the company's COVID-19 Vaccine. Moderna noted that investigation is still ongoing and the company is working closely with FDA and CDC to understand the clinical cases and whether the broad pause in use of the lot is warranted.

As per California Department of Public Health report, several individuals at one vaccination center in San Diego were treated for possible allergic reactions after vaccination from one lot of Moderna's COVID-19 Vaccine.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walmart Inc. has launched a nationwide drive to boost COVID-19 vaccination rates by reaching out to more residents in vulnerable communities. The retail giant will organize a series of community events at 43 locations in 18 states to administer the COVID-19 vaccine. Walmart said it plans to continue these new events over the next several weeks as vaccine allocations allow. Pfizer Inc. (PFE) and OPKO Health Inc. (OPK) announced Friday that the European Medicines Agency or EMA has validated for review the Marketing Authorization Application for somatrogon. Pfizer expects a decision from the European Commission in 2022. The company said somatrogon is a long-acting recombinant... German telecom giant Deutsche Telekom AG reported Friday strong growth in fourth-quarter profit mainly driven by T-Mobile US results following the takeover of the competitor Sprint. Looking ahead for fiscal 2021, the company projects higher adjusted EBITDA AL, a key earnings metric.
Follow RTT